Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
662.00    -3.00 (-0.45%)
Bid:
662.00
Ask:
663.00
Spread: 1.00 (0.151%)
Market Cap: £538.84m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Acquisition

6 Jan 2009 08:41

RNS Number : 1619L
Bloomsbury Publishing PLC
06 January 2009
 



 

Bloomsbury Publishing Plc

("Bloomsbury")

Bloomsbury acquires Arden Shakespeare

Bloomsbury Publishing Plc is pleased to announce the acquisition of Arden Shakespeare from Cengage Learning. This transaction is not material to Bloomsbury.

  Arden Shakespeare is the most academically rigorous Shakespeare series in print, and the best-known English literature brand worldwide. Originally created by the British publishing firm of Methuen in the late nineteenth century, and edited by a distinguished collection of scholars, the series took 25 years to complete from the launch of the first title, Edward Dowden's Hamlet, in 1899. In 1995 the Third Series of The Arden Shakespeare was launched. Now published under the imprint Arden Shakespeare, under the General Editorship of Richard Proudfoot, Ann Thompson, David Scott Kastan and Henry Woudhuysen, the Arden Shakespeare Third Series is nearing completion. Each new volume supersedes the corresponding Second Series text, being meticulously edited from the original sources by a contemporary scholar.

Arden Shakespeare will retain its internationally recognised name and become part of the Methuen Drama imprint (acquired in 2006 by A&C Black which is a wholly owned subsidiary of Bloomsbury). The acquisition will make Methuen Drama Europe's largest performing arts list, which includes work by Bertolt Brecht, Oscar Wilde, Bernard Shaw and Arthur Miller as well as contemporary playwrights such as Michael Frayn and Willy Russell, Methuen Student editions and the New Mermaids critical editions.

'I am delighted that the Arden Shakespeare series is returning to MethuenArden is a highly prestigious addition to our performing arts publishing and fits perfectly with our strategy of acquiring high quality perennial publishing lists which have significant potential for digital exploitation. We look forward to working with the Arden General Editors Richard Proudfoot, Ann Thompson, David Scott Kastan and Henry Woudhuysen to grow and strengthen this important list' says A&C Black Managing Director, Jill Coleman.

Jill Jones, CEO Cengage Learning EMEA said, 'The Arden Shakespeare is an excellent fit for Bloomsbury: we wish A&C Black, all volume editors, authors and General Editors from the Arden Shakespeare success for the future'.

www.methuendrama.com

-ends-

For further enquiries:

Bloomsbury Publishing PLC

Jill Coleman, Bloomsbury Publishing Plc care of Bell Pottinger

Bell Pottinger Corporate & Financial

Ben Woodford / Rosanne Perry +44 (0)20 7861 3232

Notes to Editors

About Bloomsbury Publishing Plc 

(www.bloomsbury.com and www.bloomsbury-ir.co.uk)

Bloomsbury Publishing is one of the world's leading independentpublicly quoted publishing houses with a reputation for a high quality management team and a highly valuable portfolio of intellectual properties including the Encarta World English Dictionary, JK Rowling's Harry Potter, Margaret Atwood, John Irving, David Guterson and Ben Schott. Other databases include Who's Who, Whitaker's AlmanackReed's Nautical Almanac, Black's Medical Dictionary, the Macmillan English Dictionary for Advanced Learners of EnglishBusiness: The Ultimate Resource and RSPB Handbook of British Birds. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUNOWRKKRARRR
Date   Source Headline
9th Jun 201612:43 pmRNSDirector/PDMR Shareholding
9th Jun 201612:41 pmRNSDirector/PDMR Shareholding
9th Jun 201612:41 pmRNSDirector/PDMR Shareholding
9th Jun 201612:39 pmRNSDirector/PDMR Shareholding
27th May 20162:21 pmRNSEmployee Benefit Trust purchase of shares
24th May 20164:35 pmRNSEmployee Benefit Trust purchase of shares
23rd May 201611:14 amRNSBlock Listing Six Monthly Return
19th May 20167:00 amRNSPreliminary Results
19th Apr 20163:19 pmRNSHolding(s) in Company
15th Apr 20164:22 pmRNSHolding(s) in Company
15th Apr 20164:09 pmRNSHolding(s) in Company
19th Feb 20162:12 pmRNSHolding(s) in Company
29th Jan 20166:28 pmRNSTotal Voting Rights
22nd Jan 20163:02 pmRNSCompletion of Acquisition
18th Jan 201612:20 pmRNSDirector/PDMR Shareholding
18th Jan 201612:19 pmRNSDirector/PDMR Shareholding
18th Jan 201612:17 pmRNSDirector/PDMR Shareholding
18th Jan 201612:16 pmRNSDirector/PDMR Shareholding
21st Dec 20155:35 pmRNSAcquisition
18th Nov 20155:23 pmRNSBlock Listing Six Monthly Return
27th Oct 20157:00 amRNSInterim Results
7th Oct 20153:07 pmRNSDirector/PDMR Shareholding
18th Sep 20151:04 pmRNSDirector/PDMR Shareholding
18th Sep 20151:04 pmRNSDirector/PDMR Shareholding
25th Aug 201512:08 pmRNSHolding(s) in Company
25th Aug 201512:03 pmRNSHolding(s) in Company
29th Jul 201512:53 pmRNSDirector/PDMR Shareholding
29th Jul 201512:53 pmRNSDirector/PDMR Shareholding
29th Jul 201512:49 pmRNSDirector/PDMR Shareholding
29th Jul 201512:49 pmRNSDirector/PDMR Shareholding
23rd Jul 20154:42 pmRNSAGM Statement
23rd Jul 201512:00 pmRNSDirectorate Change
23rd Jul 20157:00 amRNSTrading Statement
6th Jul 20155:36 pmRNSDirector/PDMR Shareholding
6th Jul 20155:34 pmRNSDirector/PDMR Shareholding
25th Jun 20154:54 pmRNSAnnual Financial Report
18th Jun 201511:27 amRNSHolding(s) in Company
5th Jun 20154:07 pmRNSDirector/PDMR Shareholding
4th Jun 20151:15 pmRNSHolding(s) in Company
4th Jun 20151:13 pmRNSHolding(s) in Company
28th May 20158:28 amRNSHolding(s) in Company
21st May 201510:23 amRNSDirector/PDMR Shareholding
19th May 20155:00 pmRNSBlock Listing Six Monthly Return
19th May 20157:00 amRNSPreliminary Results
18th Mar 20157:00 amRNSTrading Statement
3rd Mar 20153:30 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSTotal Voting Rights
29th Jan 20155:51 pmRNSHolding(s) in Company
9th Jan 20158:37 amRNSDirector/PDMR Shareholding
9th Jan 20158:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.